As we speak, the Meals and Drug Administration’s (FDA) eleven-person advisory committee unanimously voted, (11-0) that Eli Lilly’s anti-amyloid Alzheimer’s drug donanemab was efficient, and that…
The submit FDA Advisory Committee Recommends Approval of New Alzheimer’s Drug appeared first on Being Affected person.
